CA2375841A1 - Nouveaux composes de bispidine utiles dans le traitement des arythmies cardiaques - Google Patents
Nouveaux composes de bispidine utiles dans le traitement des arythmies cardiaques Download PDFInfo
- Publication number
- CA2375841A1 CA2375841A1 CA002375841A CA2375841A CA2375841A1 CA 2375841 A1 CA2375841 A1 CA 2375841A1 CA 002375841 A CA002375841 A CA 002375841A CA 2375841 A CA2375841 A CA 2375841A CA 2375841 A1 CA2375841 A1 CA 2375841A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- alkyl
- compounds
- diazabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010003119 arrhythmia Diseases 0.000 title claims abstract description 24
- 238000011282 treatment Methods 0.000 title claims abstract description 17
- PTPQJKANBKHDPM-UHFFFAOYSA-N 3,7-diazabicyclo[3.3.1]nonane Chemical class C1NCC2CNCC1C2 PTPQJKANBKHDPM-UHFFFAOYSA-N 0.000 title claims description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 419
- 230000006793 arrhythmia Effects 0.000 claims abstract description 15
- 238000011321 prophylaxis Methods 0.000 claims abstract description 7
- 230000001746 atrial effect Effects 0.000 claims abstract description 5
- 206010047281 Ventricular arrhythmia Diseases 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 97
- 238000006243 chemical reaction Methods 0.000 claims description 86
- 238000000034 method Methods 0.000 claims description 60
- -1 C1-4 Chemical group 0.000 claims description 49
- 125000002947 alkylene group Chemical group 0.000 claims description 36
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 36
- 125000001424 substituent group Chemical group 0.000 claims description 32
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 30
- 125000005843 halogen group Chemical group 0.000 claims description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 26
- 125000004122 cyclic group Chemical group 0.000 claims description 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 23
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- 125000003118 aryl group Chemical group 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 125000002015 acyclic group Chemical group 0.000 claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 230000009467 reduction Effects 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 14
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 125000003107 substituted aryl group Chemical group 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 7
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 229910052717 sulfur Chemical group 0.000 claims description 5
- 239000011593 sulfur Chemical group 0.000 claims description 5
- 230000029936 alkylation Effects 0.000 claims description 4
- 238000005804 alkylation reaction Methods 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 238000010511 deprotection reaction Methods 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 230000002140 halogenating effect Effects 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 10
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 6
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 1
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102220024746 rs199473444 Human genes 0.000 claims 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 204
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 134
- 239000000203 mixture Substances 0.000 description 111
- 239000000243 solution Substances 0.000 description 83
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 61
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 43
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 40
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 39
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 32
- 238000010992 reflux Methods 0.000 description 31
- 239000012044 organic layer Substances 0.000 description 26
- 239000003960 organic solvent Substances 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 25
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 20
- 229960004592 isopropanol Drugs 0.000 description 19
- 125000003545 alkoxy group Chemical group 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 238000004440 column chromatography Methods 0.000 description 14
- 239000012043 crude product Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 235000019439 ethyl acetate Nutrition 0.000 description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 238000004587 chromatography analysis Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 238000001914 filtration Methods 0.000 description 11
- 238000003818 flash chromatography Methods 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 125000006239 protecting group Chemical group 0.000 description 10
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 10
- KAAITWOSDOCHEH-UHFFFAOYSA-N 3-benzyl-3,7-diazabicyclo[3.3.1]nonane Chemical compound C1C(C2)CNCC2CN1CC1=CC=CC=C1 KAAITWOSDOCHEH-UHFFFAOYSA-N 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- ZMJREUBTESMFEN-UHFFFAOYSA-N n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1NCC2CN(C(=O)NCC)CC1C2 ZMJREUBTESMFEN-UHFFFAOYSA-N 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 7
- 239000003638 chemical reducing agent Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- DLQGGZNCJPLPQJ-UHFFFAOYSA-N 4-[3-(3,7-diazabicyclo[3.3.1]nonan-3-yl)-2-hydroxypropoxy]benzonitrile Chemical compound C1C(C2)CNCC2CN1CC(O)COC1=CC=C(C#N)C=C1 DLQGGZNCJPLPQJ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000003416 antiarrhythmic agent Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 125000005233 alkylalcohol group Chemical group 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 5
- OQJBFFCUFALWQL-UHFFFAOYSA-N n-(piperidine-1-carbonylimino)piperidine-1-carboxamide Chemical compound C1CCCCN1C(=O)N=NC(=O)N1CCCCC1 OQJBFFCUFALWQL-UHFFFAOYSA-N 0.000 description 5
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IIEJAPGXLGSUOV-UHFFFAOYSA-N 1,2-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1CCN2NC(C(=O)N)CC1C2 IIEJAPGXLGSUOV-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- SZCKSNPRMHFNIV-UHFFFAOYSA-N 2-ethyloctanamide Chemical compound CCCCCCC(CC)C(N)=O SZCKSNPRMHFNIV-UHFFFAOYSA-N 0.000 description 4
- SMFFZOQLHYIRDA-UHFFFAOYSA-N 3,4-dimethoxyphenol Chemical compound COC1=CC=C(O)C=C1OC SMFFZOQLHYIRDA-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- SYAWRASEPRCUOI-UHFFFAOYSA-N 4-[1-(3,4-dimethoxyphenoxy)but-3-enyl]benzonitrile Chemical compound C1=C(OC)C(OC)=CC=C1OC(CC=C)C1=CC=C(C#N)C=C1 SYAWRASEPRCUOI-UHFFFAOYSA-N 0.000 description 4
- ICGLPKIVTVWCFT-UHFFFAOYSA-N 4-methylbenzenesulfonohydrazide Chemical compound CC1=CC=C(S(=O)(=O)NN)C=C1 ICGLPKIVTVWCFT-UHFFFAOYSA-N 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 4
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- UAMZETBJZRERCQ-UHFFFAOYSA-N alpha-aminopropionitrile Chemical compound CC(N)C#N UAMZETBJZRERCQ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 125000006317 cyclopropyl amino group Chemical group 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 230000002336 repolarization Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ZFVNQMTWYYKBES-UHFFFAOYSA-N tert-butyl 3,7-diazabicyclo[3.3.1]nonane-3-carboxylate Chemical compound C1NCC2CN(C(=O)OC(C)(C)C)CC1C2 ZFVNQMTWYYKBES-UHFFFAOYSA-N 0.000 description 4
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- HUPCFIARGNYAJG-UHFFFAOYSA-N 3-[3-(2-propyl-1,3-dioxolan-2-yl)propyl]-3,7-diazabicyclo[3.3.1]nonane Chemical compound C1C(C2)CNCC2CN1CCCC1(CCC)OCCO1 HUPCFIARGNYAJG-UHFFFAOYSA-N 0.000 description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 3
- LLUIBOIRVHITKV-UHFFFAOYSA-N 4-[1-(3,4-dimethoxyphenoxy)-4-hydroxybutyl]benzonitrile Chemical compound C1=C(OC)C(OC)=CC=C1OC(CCCO)C1=CC=C(C#N)C=C1 LLUIBOIRVHITKV-UHFFFAOYSA-N 0.000 description 3
- QUUXDQNJCQCLFO-UHFFFAOYSA-N 7-[4-(4-cyanophenyl)-4-(3,4-dimethoxyphenoxy)butyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCCC(C=1C=CC(=CC=1)C#N)OC1=CC=C(OC)C(OC)=C1 QUUXDQNJCQCLFO-UHFFFAOYSA-N 0.000 description 3
- TWDWATDUYGORKC-UHFFFAOYSA-N 7-benzyl-n-propan-2-yl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NC(C)C)CC(C2)CC1CN2CC1=CC=CC=C1 TWDWATDUYGORKC-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- UFXKXBXIKWAQKP-UHFFFAOYSA-N bicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1CCC2CC(C(=O)N)CC1C2 UFXKXBXIKWAQKP-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 238000002565 electrocardiography Methods 0.000 description 3
- PVRMPBWWPFFWGL-UHFFFAOYSA-N ethyl 2-[[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carbonyl]amino]acetate Chemical compound C1N(C(=O)NCC(=O)OCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 PVRMPBWWPFFWGL-UHFFFAOYSA-N 0.000 description 3
- DUVOZUPPHBRJJO-UHFFFAOYSA-N ethyl 2-isocyanatoacetate Chemical compound CCOC(=O)CN=C=O DUVOZUPPHBRJJO-UHFFFAOYSA-N 0.000 description 3
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- XMWFMEYDRNJSOO-UHFFFAOYSA-N morpholine-4-carbonyl chloride Chemical compound ClC(=O)N1CCOCC1 XMWFMEYDRNJSOO-UHFFFAOYSA-N 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 3
- 239000000651 prodrug Substances 0.000 description 3
- 229940002612 prodrug Drugs 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- MCHDPOWLWCFTAU-UHFFFAOYSA-N tert-butyl 2-[(4-cyanophenoxy)methyl]aziridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC1COC1=CC=C(C#N)C=C1 MCHDPOWLWCFTAU-UHFFFAOYSA-N 0.000 description 3
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 3
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- BRLQWZUYTZBJKN-GSVOUGTGSA-N (+)-Epichlorohydrin Chemical compound ClC[C@@H]1CO1 BRLQWZUYTZBJKN-GSVOUGTGSA-N 0.000 description 2
- TXBSOGLMJVVHHI-MRVPVSSYSA-N (2r)-2-(hydroxymethyl)-3,4-dihydro-2h-1,4-benzoxazine-6-carbonitrile Chemical compound N#CC1=CC=C2O[C@@H](CO)CNC2=C1 TXBSOGLMJVVHHI-MRVPVSSYSA-N 0.000 description 2
- NUVXINPTWCHURB-UHFFFAOYSA-N (6-cyano-2,3-dihydro-1,4-benzodioxin-3-yl)methyl methanesulfonate Chemical compound C1=C(C#N)C=C2OC(COS(=O)(=O)C)COC2=C1 NUVXINPTWCHURB-UHFFFAOYSA-N 0.000 description 2
- FRNDTEVYMLZRAS-UHFFFAOYSA-N (7-benzyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)-piperidin-1-ylmethanone Chemical compound C1C(CN(CC=2C=CC=CC=2)C2)CC2CN1C(=O)N1CCCCC1 FRNDTEVYMLZRAS-UHFFFAOYSA-N 0.000 description 2
- NJCCTUQXCZTLDN-UHFFFAOYSA-N 1-[4-(oxiran-2-ylmethoxy)phenyl]imidazole Chemical compound C1OC1COC(C=C1)=CC=C1N1C=CN=C1 NJCCTUQXCZTLDN-UHFFFAOYSA-N 0.000 description 2
- MNZAKDODWSQONA-UHFFFAOYSA-N 1-dibutylphosphorylbutane Chemical compound CCCCP(=O)(CCCC)CCCC MNZAKDODWSQONA-UHFFFAOYSA-N 0.000 description 2
- QQNYLUUVDOFMRT-UHFFFAOYSA-N 1-propanoyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C(CC)(=O)C12CN(CC(CNC1)C2)C(=O)N QQNYLUUVDOFMRT-UHFFFAOYSA-N 0.000 description 2
- KBTZWENHGJQGMI-UHFFFAOYSA-N 1-propyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C(CC)C12CN(CC(CNC1)C2)C(=O)N KBTZWENHGJQGMI-UHFFFAOYSA-N 0.000 description 2
- RAZGULKVOOKKQH-UHFFFAOYSA-N 2-(3,7-diazabicyclo[3.3.1]nonan-3-yl)ethanol Chemical compound C1NCC2CN(CCO)CC1C2 RAZGULKVOOKKQH-UHFFFAOYSA-N 0.000 description 2
- SIHVSPXVPKLFAB-UHFFFAOYSA-N 2-(3-benzyl-3,7-diazabicyclo[3.3.1]nonan-7-yl)ethanol Chemical compound C1N(CCO)CC(C2)CC1CN2CC1=CC=CC=C1 SIHVSPXVPKLFAB-UHFFFAOYSA-N 0.000 description 2
- PKXQCLYHDGMERR-UHFFFAOYSA-N 2-[4,5-bis(4-cyanophenyl)pyrazol-1-yl]-n-(2-bromoethyl)acetamide Chemical compound BrCCNC(=O)CN1N=CC(C=2C=CC(=CC=2)C#N)=C1C1=CC=C(C#N)C=C1 PKXQCLYHDGMERR-UHFFFAOYSA-N 0.000 description 2
- ZDWVJYRUMXFJOU-UHFFFAOYSA-N 2-isocyanatoacetonitrile Chemical compound O=C=NCC#N ZDWVJYRUMXFJOU-UHFFFAOYSA-N 0.000 description 2
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 2
- AOELDAGSFOHVFW-UHFFFAOYSA-N 3,7-dibenzyl-3,7-diazabicyclo[3.3.1]nonane Chemical compound C=1C=CC=CC=1CN(C1)CC(C2)CC1CN2CC1=CC=CC=C1 AOELDAGSFOHVFW-UHFFFAOYSA-N 0.000 description 2
- DMKUNHJZZHMFFE-UHFFFAOYSA-N 3-(4-cyanoanilino)propyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCCNC1=CC=C(C#N)C=C1 DMKUNHJZZHMFFE-UHFFFAOYSA-N 0.000 description 2
- VSTFIPSMXSFPMK-UHFFFAOYSA-N 3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxine-6-carbonitrile Chemical compound C1=C(C#N)C=C2OC(CO)COC2=C1 VSTFIPSMXSFPMK-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- WQSHSFSXCRAXCR-UHFFFAOYSA-N 3-ethylsulfonylpropyl 4-methylbenzenesulfonate Chemical compound CCS(=O)(=O)CCCOS(=O)(=O)C1=CC=C(C)C=C1 WQSHSFSXCRAXCR-UHFFFAOYSA-N 0.000 description 2
- SJNFMGBQEOYAFH-UHFFFAOYSA-N 4-(1-hydroxybut-3-enyl)benzonitrile Chemical compound C=CCC(O)C1=CC=C(C#N)C=C1 SJNFMGBQEOYAFH-UHFFFAOYSA-N 0.000 description 2
- XRTGJOLODNFUSG-UHFFFAOYSA-N 4-(2-aminoethyl)benzonitrile Chemical compound NCCC1=CC=C(C#N)C=C1 XRTGJOLODNFUSG-UHFFFAOYSA-N 0.000 description 2
- UDZJFMWGZYXJMG-UHFFFAOYSA-N 4-(3-amino-2-hydroxypropoxy)benzonitrile Chemical compound NCC(O)COC1=CC=C(C#N)C=C1 UDZJFMWGZYXJMG-UHFFFAOYSA-N 0.000 description 2
- GGQULJYGPHOTSA-UHFFFAOYSA-N 4-(3-aminopropoxy)benzonitrile Chemical compound NCCCOC1=CC=C(C#N)C=C1 GGQULJYGPHOTSA-UHFFFAOYSA-N 0.000 description 2
- HRPASSWJHQAQCT-UHFFFAOYSA-N 4-(3-hydroxypropylamino)benzonitrile Chemical compound OCCCNC1=CC=C(C#N)C=C1 HRPASSWJHQAQCT-UHFFFAOYSA-N 0.000 description 2
- AIHOOESCXUQTEE-UHFFFAOYSA-N 4-[4-(3,7-diazabicyclo[3.3.1]nonan-3-yl)-1-(3,4-dimethoxyphenoxy)butyl]benzonitrile Chemical compound C1=C(OC)C(OC)=CC=C1OC(C=1C=CC(=CC=1)C#N)CCCN1CC(C2)CNCC2C1 AIHOOESCXUQTEE-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- CVNOWLNNPYYEOH-UHFFFAOYSA-N 4-cyanophenol Chemical compound OC1=CC=C(C#N)C=C1 CVNOWLNNPYYEOH-UHFFFAOYSA-N 0.000 description 2
- VLJQDHDVZJXNQL-UHFFFAOYSA-N 4-methyl-n-(oxomethylidene)benzenesulfonamide Chemical compound CC1=CC=C(S(=O)(=O)N=C=O)C=C1 VLJQDHDVZJXNQL-UHFFFAOYSA-N 0.000 description 2
- APCWZCSOYYLGBT-UHFFFAOYSA-N 5-bromo-2-(3-chloro-2-hydroxypropoxy)benzaldehyde Chemical compound ClCC(O)COC1=CC=C(Br)C=C1C=O APCWZCSOYYLGBT-UHFFFAOYSA-N 0.000 description 2
- XSLFWPVOVPBHRI-LLVKDONJSA-N 5-cyano-n-(2-cyanoethyl)-2-[[(2r)-oxiran-2-yl]methoxy]benzamide Chemical compound N#CCCNC(=O)C1=CC(C#N)=CC=C1OC[C@@H]1OC1 XSLFWPVOVPBHRI-LLVKDONJSA-N 0.000 description 2
- YTOHUZIMTOKJRC-UHFFFAOYSA-N 5-cyano-n-(2-cyanoethyl)-2-hydroxybenzamide Chemical compound OC1=CC=C(C#N)C=C1C(=O)NCCC#N YTOHUZIMTOKJRC-UHFFFAOYSA-N 0.000 description 2
- FEKQDICRDNUAQD-UHFFFAOYSA-N 5-cyano-n-cyclopropyl-2-(oxiran-2-ylmethoxy)benzamide Chemical compound C=1C(C#N)=CC=C(OCC2OC2)C=1C(=O)NC1CC1 FEKQDICRDNUAQD-UHFFFAOYSA-N 0.000 description 2
- ZBNXIWJQAAKKMI-UHFFFAOYSA-N 7-[2-amino-3-(4-cyanophenoxy)propyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(N)COC1=CC=C(C#N)C=C1 ZBNXIWJQAAKKMI-UHFFFAOYSA-N 0.000 description 2
- POXKLWKQALWMCJ-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(cyclopropylmethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NCC3CC3)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 POXKLWKQALWMCJ-UHFFFAOYSA-N 0.000 description 2
- UZGZHRUYKRIJPO-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 UZGZHRUYKRIJPO-UHFFFAOYSA-N 0.000 description 2
- PPKYQYSVEGBNIB-UHFFFAOYSA-N 7-benzyl-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC1=CC=CC=C1 PPKYQYSVEGBNIB-UHFFFAOYSA-N 0.000 description 2
- ROABNRTYURZPCY-UHFFFAOYSA-N 7-benzyl-n-phenyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(CC=2C=CC=CC=2)C2)CC2CN1C(=O)NC1=CC=CC=C1 ROABNRTYURZPCY-UHFFFAOYSA-N 0.000 description 2
- ONMOULMPIIOVTQ-UHFFFAOYSA-N 98-47-5 Chemical compound OS(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 ONMOULMPIIOVTQ-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 229910010084 LiAlH4 Inorganic materials 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 150000001204 N-oxides Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- QWULWORGCMXUOW-UHFFFAOYSA-N [5-bromo-2-(3-chloro-2-hydroxypropoxy)phenyl] formate Chemical compound ClCC(O)COC1=CC=C(Br)C=C1OC=O QWULWORGCMXUOW-UHFFFAOYSA-N 0.000 description 2
- 230000036982 action potential Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 125000005604 azodicarboxylate group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003857 carboxamides Chemical class 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- IGSKHXTUVXSOMB-UHFFFAOYSA-N cyclopropylmethanamine Chemical compound NCC1CC1 IGSKHXTUVXSOMB-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- YSQPOLKQRGYSMJ-UHFFFAOYSA-N ethyl 2-[4,5-bis(4-cyanophenyl)pyrazol-1-yl]acetate Chemical compound CCOC(=O)CN1N=CC(C=2C=CC(=CC=2)C#N)=C1C1=CC=C(C#N)C=C1 YSQPOLKQRGYSMJ-UHFFFAOYSA-N 0.000 description 2
- 238000010265 fast atom bombardment Methods 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- GVCHRKKMNKWGDS-UHFFFAOYSA-N isocyanatomethylcyclopropane Chemical compound O=C=NCC1CC1 GVCHRKKMNKWGDS-UHFFFAOYSA-N 0.000 description 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- WNLGGSGBOQGUHV-UHFFFAOYSA-N methyl 5-cyano-2-hydroxybenzoate Chemical compound COC(=O)C1=CC(C#N)=CC=C1O WNLGGSGBOQGUHV-UHFFFAOYSA-N 0.000 description 2
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- KCGFBAGHKFZGNQ-UHFFFAOYSA-N n-(1-cyanoethyl)-7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NC(C)C#N)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 KCGFBAGHKFZGNQ-UHFFFAOYSA-N 0.000 description 2
- YCPVIPRRTDZMLO-UHFFFAOYSA-N n-[1-(4-cyanophenoxy)-3-(3,7-diazabicyclo[3.3.1]nonan-3-yl)propan-2-yl]methanesulfonamide Chemical compound C1C(C2)CNCC2CN1CC(NS(=O)(=O)C)COC1=CC=C(C#N)C=C1 YCPVIPRRTDZMLO-UHFFFAOYSA-N 0.000 description 2
- FXPGASVLFUXNML-UHFFFAOYSA-N n-[3-(4-cyanophenoxy)propyl]-7-(2-hydroxyethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(CCO)CC(C2)CC1CN2C(=O)NCCCOC1=CC=C(C#N)C=C1 FXPGASVLFUXNML-UHFFFAOYSA-N 0.000 description 2
- ZPRWHKDEMKKYTF-UHFFFAOYSA-N n-ethyl-7-[2-hydroxy-3-(4-imidazol-1-ylphenoxy)propyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(O)COC(C=C1)=CC=C1N1C=CN=C1 ZPRWHKDEMKKYTF-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- AIHIHVZYAAMDPM-UHFFFAOYSA-N oxiran-2-ylmethyl 3-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=CC=CC(S(=O)(=O)OCC2OC2)=C1 AIHIHVZYAAMDPM-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 2
- ICDKVRSJNQPBTR-UHFFFAOYSA-N tert-butyl 7-[(4-cyanophenyl)carbamoyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC(C2)CC1CN2C(=O)NC1=CC=C(C#N)C=C1 ICDKVRSJNQPBTR-UHFFFAOYSA-N 0.000 description 2
- JFLCCGFMLBSXBA-UHFFFAOYSA-N tert-butyl 7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC(C2)CC1CN2CC1=CC=CC=C1 JFLCCGFMLBSXBA-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical compound ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- DLNAKYFPFYUBDR-UHFFFAOYSA-N (4-aminophenyl)-(7-benzyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1CC(CN(CC=2C=CC=CC=2)C2)CC2C1 DLNAKYFPFYUBDR-UHFFFAOYSA-N 0.000 description 1
- DLNAKYFPFYUBDR-HDICACEKSA-N (4-aminophenyl)-[(1s,5r)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-3-yl]methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1C[C@@H](CN(CC=2C=CC=CC=2)C2)C[C@@H]2C1 DLNAKYFPFYUBDR-HDICACEKSA-N 0.000 description 1
- FTABKDGWKNKXQJ-UHFFFAOYSA-N (4-chlorophenyl)-(7-propan-2-yl-3,7-diazabicyclo[3.3.1]nonan-3-yl)methanone Chemical compound C1N(C(C)C)CC(C2)CC1CN2C(=O)C1=CC=C(Cl)C=C1 FTABKDGWKNKXQJ-UHFFFAOYSA-N 0.000 description 1
- FJGPKNZNSQTEAL-UHFFFAOYSA-N (6-bromo-2,3-dihydro-1,4-benzodioxin-3-yl)methanol Chemical compound C1=C(Br)C=C2OC(CO)COC2=C1 FJGPKNZNSQTEAL-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-GSVOUGTGSA-N (R)-Glycidol Chemical compound OC[C@@H]1CO1 CTKINSOISVBQLD-GSVOUGTGSA-N 0.000 description 1
- KTSZYXNHBVWNNV-UHFFFAOYSA-N 1,2-diazabicyclo[3.3.1]nonane Chemical compound C1CNN2CCCC1C2 KTSZYXNHBVWNNV-UHFFFAOYSA-N 0.000 description 1
- XGNXYCFREOZBOL-UHFFFAOYSA-N 1,3-benzodioxol-5-amine Chemical compound NC1=CC=C2OCOC2=C1 XGNXYCFREOZBOL-UHFFFAOYSA-N 0.000 description 1
- NTURQZFFJDCTMZ-UHFFFAOYSA-N 1-(2-bromoethyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(CCBr)C=C1 NTURQZFFJDCTMZ-UHFFFAOYSA-N 0.000 description 1
- YKSFESKWULBWPE-UHFFFAOYSA-N 1-(cyclopropylmethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1(CC1)CC12CN(CC(CNC1)C2)C(=O)N YKSFESKWULBWPE-UHFFFAOYSA-N 0.000 description 1
- MVXAQUVHQBGAKB-UHFFFAOYSA-N 1-[2-(cyclopropylmethylamino)-2-oxoethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1(CC1)CNC(CC12CN(CC(CNC1)C2)C(=O)N)=O MVXAQUVHQBGAKB-UHFFFAOYSA-N 0.000 description 1
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
- KAJZMNLREUEZSH-UHFFFAOYSA-N 2-(2-isocyanatoethyl)thiophene Chemical compound O=C=NCCC1=CC=CS1 KAJZMNLREUEZSH-UHFFFAOYSA-N 0.000 description 1
- INRNFOINQWRSFI-UHFFFAOYSA-N 2-(3-bromopropyl)-2-propyl-1,3-dioxolane Chemical compound BrCCCC1(CCC)OCCO1 INRNFOINQWRSFI-UHFFFAOYSA-N 0.000 description 1
- QXHDYMUPPXAMPQ-UHFFFAOYSA-N 2-(4-aminophenyl)ethanol Chemical compound NC1=CC=C(CCO)C=C1 QXHDYMUPPXAMPQ-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- GXXQCGYEGFMAQC-UHFFFAOYSA-N 2-[4-(methanesulfonamido)phenyl]ethyl methanesulfonate;methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O.CS(=O)(=O)NC1=CC=C(CCOS(C)(=O)=O)C=C1 GXXQCGYEGFMAQC-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- LJGHKRYNFCAMCA-UHFFFAOYSA-N 3,7-diazabicyclo[3.3.1]nonan-3-yl(piperidin-1-yl)methanone Chemical compound C1C(C2)CNCC2CN1C(=O)N1CCCCC1 LJGHKRYNFCAMCA-UHFFFAOYSA-N 0.000 description 1
- VDPCIZXWEQHOJC-UHFFFAOYSA-N 3,7-dibenzyl-3,7-diazabicyclo[3.3.1]nonan-9-one Chemical compound C1C(CN(CC=2C=CC=CC=2)C2)C(=O)C2CN1CC1=CC=CC=C1 VDPCIZXWEQHOJC-UHFFFAOYSA-N 0.000 description 1
- ZEWCASRNRWXXSO-UHFFFAOYSA-N 3-amino-4-hydroxybenzonitrile Chemical compound NC1=CC(C#N)=CC=C1O ZEWCASRNRWXXSO-UHFFFAOYSA-N 0.000 description 1
- LHUWGMIFIFULPE-UHFFFAOYSA-N 3-benzyl-7-[3-(2-propyl-1,3-dioxolan-2-yl)propyl]-3,7-diazabicyclo[3.3.1]nonane Chemical compound C1C(CN(CC=2C=CC=CC=2)C2)CC2CN1CCCC1(CCC)OCCO1 LHUWGMIFIFULPE-UHFFFAOYSA-N 0.000 description 1
- HHFKLDKATFBFMU-UHFFFAOYSA-N 3-bicyclo[3.3.1]nonanyl(piperidin-1-yl)methanone Chemical compound C12CC(CC(CCC1)C2)C(=O)N2CCCCC2 HHFKLDKATFBFMU-UHFFFAOYSA-N 0.000 description 1
- JEQIUOSLBOSOPN-UHFFFAOYSA-N 3-ethylsulfonylpropan-1-ol Chemical compound CCS(=O)(=O)CCCO JEQIUOSLBOSOPN-UHFFFAOYSA-N 0.000 description 1
- IFVNEJLHHCHXGX-UHFFFAOYSA-N 3-hydroxypropylcarbamic acid Chemical compound OCCCNC(O)=O IFVNEJLHHCHXGX-UHFFFAOYSA-N 0.000 description 1
- MWWNNNAOGWPTQY-UHFFFAOYSA-N 3-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(S(Cl)(=O)=O)=C1 MWWNNNAOGWPTQY-UHFFFAOYSA-N 0.000 description 1
- CYKCUAPYWQDIKR-UHFFFAOYSA-N 4-(1h-imidazol-1-yl)phenol Chemical compound C1=CC(O)=CC=C1N1C=NC=C1 CYKCUAPYWQDIKR-UHFFFAOYSA-N 0.000 description 1
- ZIUYNDUOFPXUOD-UHFFFAOYSA-N 4-(3-bromopropoxy)benzonitrile Chemical compound BrCCCOC1=CC=C(C#N)C=C1 ZIUYNDUOFPXUOD-UHFFFAOYSA-N 0.000 description 1
- WPOPTIIJKVHDCY-UHFFFAOYSA-N 4-(3-bromopropoxy)benzonitrile;1,3-dibromopropane Chemical compound BrCCCBr.BrCCCOC1=CC=C(C#N)C=C1 WPOPTIIJKVHDCY-UHFFFAOYSA-N 0.000 description 1
- WANDYUHWUAJSBK-UHFFFAOYSA-N 4-(oxiran-2-ylmethoxy)-1h-indole-2-carbonitrile Chemical compound C1=CC=C2NC(C#N)=CC2=C1OCC1CO1 WANDYUHWUAJSBK-UHFFFAOYSA-N 0.000 description 1
- WREXVDPOLDOXJL-UHFFFAOYSA-N 4-(oxiran-2-ylmethoxy)benzonitrile Chemical compound C1=CC(C#N)=CC=C1OCC1OC1 WREXVDPOLDOXJL-UHFFFAOYSA-N 0.000 description 1
- ZUGRGKRTDDJGCX-UHFFFAOYSA-N 4-[(1-methylsulfonylaziridin-2-yl)methoxy]benzonitrile Chemical compound CS(=O)(=O)N1CC1COC1=CC=C(C#N)C=C1 ZUGRGKRTDDJGCX-UHFFFAOYSA-N 0.000 description 1
- VYXDPEJDRQQDNP-QGOAFFKASA-N 4-[(e)-3-(4-cyanophenyl)-1-(dimethylamino)-3-oxoprop-1-en-2-yl]benzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(=C/N(C)C)\C(=O)C1=CC=C(C#N)C=C1 VYXDPEJDRQQDNP-QGOAFFKASA-N 0.000 description 1
- BODMSQVRHORRAI-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-oxoethyl]benzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(=O)CC1=CC=C(C#N)C=C1 BODMSQVRHORRAI-UHFFFAOYSA-N 0.000 description 1
- AMBQBWZOPBWYQC-UHFFFAOYSA-N 4-[2-amino-3-[3-(piperidine-1-carbonyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]propoxy]benzonitrile Chemical compound C1C(CN(C2)C(=O)N3CCCCC3)CC2CN1CC(N)COC1=CC=C(C#N)C=C1 AMBQBWZOPBWYQC-UHFFFAOYSA-N 0.000 description 1
- JVSQQQCDNYRHHK-UHFFFAOYSA-N 4-[3-(1,3-dioxoisoindol-2-yl)propoxy]benzonitrile Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCOC1=CC=C(C#N)C=C1 JVSQQQCDNYRHHK-UHFFFAOYSA-N 0.000 description 1
- ANUXRPYXFCOIAD-UHFFFAOYSA-N 4-[3-[3-(2,6-dimethylmorpholine-4-carbonyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]-2-hydroxypropoxy]benzonitrile Chemical compound C1C(C)OC(C)CN1C(=O)N1CC(CN(CC(O)COC=2C=CC(=CC=2)C#N)C2)CC2C1 ANUXRPYXFCOIAD-UHFFFAOYSA-N 0.000 description 1
- WREXVDPOLDOXJL-JTQLQIEISA-N 4-[[(2r)-oxiran-2-yl]methoxy]benzonitrile Chemical compound C1=CC(C#N)=CC=C1OC[C@@H]1OC1 WREXVDPOLDOXJL-JTQLQIEISA-N 0.000 description 1
- WREXVDPOLDOXJL-SNVBAGLBSA-N 4-[[(2s)-oxiran-2-yl]methoxy]benzonitrile Chemical compound C1=CC(C#N)=CC=C1OC[C@H]1OC1 WREXVDPOLDOXJL-SNVBAGLBSA-N 0.000 description 1
- PJWRZYGGTHXGQO-UHFFFAOYSA-N 4-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=C(C#N)C=C1 PJWRZYGGTHXGQO-UHFFFAOYSA-N 0.000 description 1
- AEKVBBNGWBBYLL-UHFFFAOYSA-N 4-fluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1 AEKVBBNGWBBYLL-UHFFFAOYSA-N 0.000 description 1
- TVSXDZNUTPLDKY-UHFFFAOYSA-N 4-isocyanatobenzonitrile Chemical compound O=C=NC1=CC=C(C#N)C=C1 TVSXDZNUTPLDKY-UHFFFAOYSA-N 0.000 description 1
- MKKSTJKBKNCMRV-UHFFFAOYSA-N 5-bromo-2-hydroxybenzaldehyde Chemical compound OC1=CC=C(Br)C=C1C=O MKKSTJKBKNCMRV-UHFFFAOYSA-N 0.000 description 1
- ZDQDBCKUACOSSR-UHFFFAOYSA-N 5-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1NCC2CN(C(N)=O)CC1(CC)C2 ZDQDBCKUACOSSR-UHFFFAOYSA-N 0.000 description 1
- POXKLWKQALWMCJ-SOAGJPPSSA-N 7-[(2r)-3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(cyclopropylmethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@H](O)CN1CC2CC(CN(C2)C(=O)NCC2CC2)C1)OC1=CC=C(C#N)C=C1 POXKLWKQALWMCJ-SOAGJPPSSA-N 0.000 description 1
- UZGZHRUYKRIJPO-DAWZGUTISA-N 7-[(2r)-3-(4-cyanophenoxy)-2-hydroxypropyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@H](O)CN1CC2CC(C1)CN(C2)C(=O)NCC)OC1=CC=C(C#N)C=C1 UZGZHRUYKRIJPO-DAWZGUTISA-N 0.000 description 1
- FEABECDAAYFSAR-OFLPRAFFSA-N 7-[(2r)-3-(4-cyanophenoxy)-2-hydroxypropyl]-n-methyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@H](O)CN1CC2CC(C1)CN(C2)C(=O)NC)OC1=CC=C(C#N)C=C1 FEABECDAAYFSAR-OFLPRAFFSA-N 0.000 description 1
- WWNWCDDANJKOGL-CTWPCTMYSA-N 7-[(2r)-3-(4-cyanophenoxy)-2-hydroxypropyl]-n-propyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@H](O)CN1CC2CC(C1)CN(C2)C(=O)NCCC)OC1=CC=C(C#N)C=C1 WWNWCDDANJKOGL-CTWPCTMYSA-N 0.000 description 1
- ADOPPEFAHBQZIS-ABHNRTSZSA-N 7-[(2s)-3-(4-cyanophenoxy)-2-hydroxypropyl]-n,n-dimethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@@H](O)CN1CC2CC(C1)CN(C2)C(=O)N(C)C)OC1=CC=C(C#N)C=C1 ADOPPEFAHBQZIS-ABHNRTSZSA-N 0.000 description 1
- UZGZHRUYKRIJPO-ABHNRTSZSA-N 7-[(2s)-3-(4-cyanophenoxy)-2-hydroxypropyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@@H](O)CN1CC2CC(C1)CN(C2)C(=O)NCC)OC1=CC=C(C#N)C=C1 UZGZHRUYKRIJPO-ABHNRTSZSA-N 0.000 description 1
- ATTYYKIUEHURDN-UHFFFAOYSA-N 7-[2-(4-cyanophenoxy)ethyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCOC1=CC=C(C#N)C=C1 ATTYYKIUEHURDN-UHFFFAOYSA-N 0.000 description 1
- UGRMLWAFWBPHEW-UHFFFAOYSA-N 7-[2-(4-cyanophenyl)-2-hydroxyethyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(O)C1=CC=C(C#N)C=C1 UGRMLWAFWBPHEW-UHFFFAOYSA-N 0.000 description 1
- PJASCRMNPMAXNQ-UHFFFAOYSA-N 7-[2-[[2-[4,5-bis(4-cyanophenyl)pyrazol-1-yl]acetyl]amino]ethyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCNC(=O)CN1N=CC(C=2C=CC(=CC=2)C#N)=C1C1=CC=C(C#N)C=C1 PJASCRMNPMAXNQ-UHFFFAOYSA-N 0.000 description 1
- BKPBTDORIZRQSO-UHFFFAOYSA-N 7-[2-amino-3-(4-cyanophenoxy)propyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(N)=O)CC2CN1CC(N)COC1=CC=C(C#N)C=C1 BKPBTDORIZRQSO-UHFFFAOYSA-N 0.000 description 1
- JLACVKMSQUHAGM-UHFFFAOYSA-N 7-[2-amino-4-(4-cyanophenoxy)butyl]-n-propyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCCC)CC(C2)CC1CN2CC(N)CCOC1=CC=C(C#N)C=C1 JLACVKMSQUHAGM-UHFFFAOYSA-N 0.000 description 1
- YTROLHVUKLIOSH-UHFFFAOYSA-N 7-[3-(2,4-dicyanophenoxy)-2-hydroxypropyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1C#N YTROLHVUKLIOSH-UHFFFAOYSA-N 0.000 description 1
- GCCFUZZBKYCIFL-UHFFFAOYSA-N 7-[3-(4-cyanoanilino)propyl]-n-[2-oxo-2-(propylamino)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC(=O)NCCC)CC(C2)CC1CN2CCCNC1=CC=C(C#N)C=C1 GCCFUZZBKYCIFL-UHFFFAOYSA-N 0.000 description 1
- YXNSLNYLFRRSEK-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-(methanesulfonamido)propyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(NS(C)(=O)=O)COC1=CC=C(C#N)C=C1 YXNSLNYLFRRSEK-UHFFFAOYSA-N 0.000 description 1
- HRFFBPHHBIMSRO-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-fluoropropyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(F)COC1=CC=C(C#N)C=C1 HRFFBPHHBIMSRO-UHFFFAOYSA-N 0.000 description 1
- CMDJZYNBSQJQGY-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)N)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 CMDJZYNBSQJQGY-UHFFFAOYSA-N 0.000 description 1
- LNGVXXUSVGHFFJ-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(2,2,2-trifluoroethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NCC(F)(F)F)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 LNGVXXUSVGHFFJ-UHFFFAOYSA-N 0.000 description 1
- BEABLDKGAZDROM-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(2,2-dimethylpropanoyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NC(=O)C(C)(C)C)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 BEABLDKGAZDROM-UHFFFAOYSA-N 0.000 description 1
- ATDCIISFPJYSGS-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(2,6-dimethoxyphenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound COC1=CC=CC(OC)=C1NC(=O)N1CC(CN(CC(O)COC=2C=CC(=CC=2)C#N)C2)CC2C1 ATDCIISFPJYSGS-UHFFFAOYSA-N 0.000 description 1
- NXSKVDWKGDQDOU-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(2,6-dimethylphenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound CC1=CC=CC(C)=C1NC(=O)N1CC(CN(CC(O)COC=2C=CC(=CC=2)C#N)C2)CC2C1 NXSKVDWKGDQDOU-UHFFFAOYSA-N 0.000 description 1
- ASACPWVVSMDPBQ-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(3,4,5-trimethoxyphenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N2CC3CC(CN(CC(O)COC=4C=CC(=CC=4)C#N)C3)C2)=C1 ASACPWVVSMDPBQ-UHFFFAOYSA-N 0.000 description 1
- RUTYGHTUFQDADN-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(3,4-dihydro-2h-1,5-benzodioxepin-7-yl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NC=3C=C4OCCCOC4=CC=3)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 RUTYGHTUFQDADN-UHFFFAOYSA-N 0.000 description 1
- XPIBQNGSGFEMRL-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(3,4-dimethoxyphenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1NC(=O)N1CC(CN(CC(O)COC=2C=CC(=CC=2)C#N)C2)CC2C1 XPIBQNGSGFEMRL-UHFFFAOYSA-N 0.000 description 1
- FLHXGIXXFZBSAS-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(3-cyanophenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NC=3C=C(C=CC=3)C#N)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 FLHXGIXXFZBSAS-UHFFFAOYSA-N 0.000 description 1
- NORLLUDUITXKHU-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(4-cyanophenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NC=3C=CC(=CC=3)C#N)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 NORLLUDUITXKHU-UHFFFAOYSA-N 0.000 description 1
- WPBYQIILZLHBNN-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-(4-methylphenyl)sulfonyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)N1CC(CN(CC(O)COC=2C=CC(=CC=2)C#N)C2)CC2C1 WPBYQIILZLHBNN-UHFFFAOYSA-N 0.000 description 1
- SOHMWZHGDCPNFD-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-[2-(2-methoxyethoxy)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCCOCCOC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 SOHMWZHGDCPNFD-UHFFFAOYSA-N 0.000 description 1
- KXSGQVDLPJFCHM-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-[2-oxo-2-(propylamino)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC(=O)NCCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 KXSGQVDLPJFCHM-UHFFFAOYSA-N 0.000 description 1
- CBNHBHHNSMNQIX-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-[3-(ethylamino)-3-oxopropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCCC(=O)NCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 CBNHBHHNSMNQIX-UHFFFAOYSA-N 0.000 description 1
- BJUGHIITZQVWAV-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-cyclopropyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NC3CC3)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 BJUGHIITZQVWAV-UHFFFAOYSA-N 0.000 description 1
- FZPBEDXMKIZGTJ-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-hexyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCCCCCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 FZPBEDXMKIZGTJ-UHFFFAOYSA-N 0.000 description 1
- WWNWCDDANJKOGL-UHFFFAOYSA-N 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-propyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 WWNWCDDANJKOGL-UHFFFAOYSA-N 0.000 description 1
- SPANXJIIKVKJPC-UHFFFAOYSA-N 7-[4-(4-cyanophenoxy)-2-hydroxybutyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(O)CCOC1=CC=C(C#N)C=C1 SPANXJIIKVKJPC-UHFFFAOYSA-N 0.000 description 1
- ANUJAHGGNZKPKL-UHFFFAOYSA-N 7-[4-(4-cyanophenyl)-4-hydroxybutyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCCC(O)C1=CC=C(C#N)C=C1 ANUJAHGGNZKPKL-UHFFFAOYSA-N 0.000 description 1
- MHWODKUBMLMRBN-UHFFFAOYSA-N 7-[4-(4-cyanophenyl)butyl]-n-ethyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCCCC1=CC=C(C#N)C=C1 MHWODKUBMLMRBN-UHFFFAOYSA-N 0.000 description 1
- GJPDVYKENCWXTH-UHFFFAOYSA-N 7-[4-(4-cyanophenyl)butyl]-n-propyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCCC)CC(C2)CC1CN2CCCCC1=CC=C(C#N)C=C1 GJPDVYKENCWXTH-UHFFFAOYSA-N 0.000 description 1
- DLVPLIXWVVWLAI-UHFFFAOYSA-N 7-benzyl-n-[2-oxo-2-(propylamino)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC(=O)NCCC)CC(C2)CC1CN2CC1=CC=CC=C1 DLVPLIXWVVWLAI-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- DMZZWTABKXNGAC-UHFFFAOYSA-N BrC=1C=CC(=C(C(=O)OC)C1)O.C(#N)C=1C=CC(=C(C(=O)OC)C1)O Chemical compound BrC=1C=CC(=C(C(=O)OC)C1)O.C(#N)C=1C=CC(=C(C(=O)OC)C1)O DMZZWTABKXNGAC-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000018452 Torsade de pointes Diseases 0.000 description 1
- 208000002363 Torsades de Pointes Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- GNJAWYVGKKDNND-UHFFFAOYSA-N [1-(4-cyanophenoxy)-3-(methanesulfonamido)propan-2-yl] methanesulfonate Chemical compound CS(=O)(=O)NCC(OS(C)(=O)=O)COC1=CC=C(C#N)C=C1 GNJAWYVGKKDNND-UHFFFAOYSA-N 0.000 description 1
- GNCZCKKIFRXCEB-UHFFFAOYSA-N [1-(4-cyanophenoxy)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propan-2-yl] methanesulfonate Chemical compound CC(C)(C)OC(=O)NCC(OS(C)(=O)=O)COC1=CC=C(C#N)C=C1 GNCZCKKIFRXCEB-UHFFFAOYSA-N 0.000 description 1
- ZLQRCDUCUQIRPF-UHFFFAOYSA-N [4-(4-cyanophenyl)-4-(3,4-dimethoxyphenoxy)butyl] methanesulfonate Chemical compound C1=C(OC)C(OC)=CC=C1OC(CCCOS(C)(=O)=O)C1=CC=C(C#N)C=C1 ZLQRCDUCUQIRPF-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical compound OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229950005516 ambasilide Drugs 0.000 description 1
- DFNYGALUNNFWKJ-UHFFFAOYSA-N aminoacetonitrile Chemical compound NCC#N DFNYGALUNNFWKJ-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- AGSPXMVUFBBBMO-UHFFFAOYSA-N beta-aminopropionitrile Chemical compound NCCC#N AGSPXMVUFBBBMO-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- PMCPYLGCPSNSLS-FOLVSLTJSA-N bisaramil Chemical compound CCN1C[C@@H]2CN(C)C[C@H](C1)[C@@H]2OC(=O)C1=CC=C(Cl)C=C1 PMCPYLGCPSNSLS-FOLVSLTJSA-N 0.000 description 1
- 229950007885 bisaramil Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- QHAJWTUJFDQUAG-UHFFFAOYSA-N butyl 2-[[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carbonyl]amino]acetate Chemical compound C1N(C(=O)NCC(=O)OCCCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 QHAJWTUJFDQUAG-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 230000011128 cardiac conduction Effects 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- PLUFJKIDKZXRGF-UHFFFAOYSA-N ethyl 2-[(7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carbonyl)amino]acetate Chemical compound C1N(C(=O)NCC(=O)OCC)CC(C2)CC1CN2CC1=CC=CC=C1 PLUFJKIDKZXRGF-UHFFFAOYSA-N 0.000 description 1
- HZZRIIPYFPIKHR-UHFFFAOYSA-N ethyl 2-hydrazinylacetate;hydron;chloride Chemical compound Cl.CCOC(=O)CNN HZZRIIPYFPIKHR-UHFFFAOYSA-N 0.000 description 1
- XBSGYVHOINMTIM-UHFFFAOYSA-N ethyl 3-isocyanatopropanoate Chemical compound CCOC(=O)CCN=C=O XBSGYVHOINMTIM-UHFFFAOYSA-N 0.000 description 1
- XLMDONVBXBUDQL-UHFFFAOYSA-N ethyl n-[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carbonyl]carbamate Chemical compound C1N(C(=O)NC(=O)OCC)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 XLMDONVBXBUDQL-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- CUICPJOPYVMUPK-UHFFFAOYSA-N ethyl n-tert-butylcarbamate Chemical compound CCOC(=O)NC(C)(C)C CUICPJOPYVMUPK-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000001435 haemodynamic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- WOFDVDFSGLBFAC-UHFFFAOYSA-N lactonitrile Chemical group CC(O)C#N WOFDVDFSGLBFAC-UHFFFAOYSA-N 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- IJYKAYQZCLMRKY-UHFFFAOYSA-N methanesulfonic acid;methanesulfonyl chloride Chemical compound CS(O)(=O)=O.CS(Cl)(=O)=O IJYKAYQZCLMRKY-UHFFFAOYSA-N 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- FJYDBKPPGRZSOZ-UHFFFAOYSA-N methyl 5-bromo-2-hydroxybenzoate Chemical compound COC(=O)C1=CC(Br)=CC=C1O FJYDBKPPGRZSOZ-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- ZPQARJYCBUUUHU-UHFFFAOYSA-N n'-(4-cyanobenzoyl)-7-(4-oxoheptyl)-3,7-diazabicyclo[3.3.1]nonane-3-carbohydrazide Chemical compound C1N(CCCC(=O)CCC)CC(C2)CC1CN2C(=O)NNC(=O)C1=CC=C(C#N)C=C1 ZPQARJYCBUUUHU-UHFFFAOYSA-N 0.000 description 1
- FXRUEDNPTLHZER-UHFFFAOYSA-N n-(1,3-benzodioxol-5-yl)-7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NC=3C=C4OCOC4=CC=3)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 FXRUEDNPTLHZER-UHFFFAOYSA-N 0.000 description 1
- JFLHPLRXTLDMIQ-UHFFFAOYSA-N n-(4-butoxyphenyl)-7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1=CC(OCCCC)=CC=C1NC(=O)N1CC(CN(CC(O)COC=2C=CC(=CC=2)C#N)C2)CC2C1 JFLHPLRXTLDMIQ-UHFFFAOYSA-N 0.000 description 1
- OWGIMDWMLFKIHC-UHFFFAOYSA-N n-(4-cyanophenyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(C2)CNCC2CN1C(=O)NC1=CC=C(C#N)C=C1 OWGIMDWMLFKIHC-UHFFFAOYSA-N 0.000 description 1
- ATNHEEJOFIAYQT-UHFFFAOYSA-N n-(4-cyanophenyl)-7-(3,3-dimethyl-2-oxobutyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(CC(=O)C(C)(C)C)CC(C2)CC1CN2C(=O)NC1=CC=C(C#N)C=C1 ATNHEEJOFIAYQT-UHFFFAOYSA-N 0.000 description 1
- KAIKOEWVNSJIEL-UHFFFAOYSA-N n-(4-cyanophenyl)-7-(4-oxoheptyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(CCCC(=O)CCC)CC(C2)CC1CN2C(=O)NC1=CC=C(C#N)C=C1 KAIKOEWVNSJIEL-UHFFFAOYSA-N 0.000 description 1
- GUGOWJASNVVVDP-UHFFFAOYSA-N n-(4-cyanophenyl)-7-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C=1C=C2OCCOC2=CC=1C(=O)CN(C1)CC(C2)CC1CN2C(=O)NC1=CC=C(C#N)C=C1 GUGOWJASNVVVDP-UHFFFAOYSA-N 0.000 description 1
- PLIAJBUTGVLWSH-UHFFFAOYSA-N n-(4-cyanophenyl)-7-[2-(2-methoxyethoxy)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(CCOCCOC)CC(C2)CC1CN2C(=O)NC1=CC=C(C#N)C=C1 PLIAJBUTGVLWSH-UHFFFAOYSA-N 0.000 description 1
- PQYGETXUCWFVDD-UHFFFAOYSA-N n-(4-nitrophenyl)-7-(4-oxoheptyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(CCCC(=O)CCC)CC(C2)CC1CN2C(=O)NC1=CC=C([N+]([O-])=O)C=C1 PQYGETXUCWFVDD-UHFFFAOYSA-N 0.000 description 1
- LQCSDOSIGLURNC-UHFFFAOYSA-N n-(cyanomethyl)-7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-n-methyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)N(CC#N)C)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 LQCSDOSIGLURNC-UHFFFAOYSA-N 0.000 description 1
- FQMJTXROGMVCAX-UHFFFAOYSA-N n-[1-(4-cyanophenoxy)-3-[3-(ethylcarbamoyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]propan-2-yl]morpholine-4-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(NC(=O)N1CCOCC1)COC1=CC=C(C#N)C=C1 FQMJTXROGMVCAX-UHFFFAOYSA-N 0.000 description 1
- CUIFDVJEFHYCEM-UHFFFAOYSA-N n-[1-(7-benzyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)-3-(4-cyanophenoxy)propan-2-yl]methanesulfonamide Chemical compound C1C(CN(CC=2C=CC=CC=2)C2)CC2CN1CC(NS(=O)(=O)C)COC1=CC=C(C#N)C=C1 CUIFDVJEFHYCEM-UHFFFAOYSA-N 0.000 description 1
- LGBLUTLPOSQAON-UHFFFAOYSA-N n-[2-oxo-2-(propylamino)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1NCC2CN(C(=O)NCC(=O)NCCC)CC1C2 LGBLUTLPOSQAON-UHFFFAOYSA-N 0.000 description 1
- PXTNHRMQZFCFBP-UHFFFAOYSA-N n-[3-(4-cyanophenoxy)propyl]-7-[5-(ethylamino)-5-oxopentyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(CCCCC(=O)NCC)CC(C2)CC1CN2C(=O)NCCCOC1=CC=C(C#N)C=C1 PXTNHRMQZFCFBP-UHFFFAOYSA-N 0.000 description 1
- FANZLYHWFHMPID-UHFFFAOYSA-N n-[cyano-(4-fluorophenyl)methyl]-7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NC(C#N)C=3C=CC(F)=CC=3)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 FANZLYHWFHMPID-UHFFFAOYSA-N 0.000 description 1
- OTZBBHGQZWHYCT-DAWZGUTISA-N n-acetyl-7-[(2r)-3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C([C@H](O)CN1CC2CC(C1)CN(C2)C(=O)NC(=O)C)OC1=CC=C(C#N)C=C1 OTZBBHGQZWHYCT-DAWZGUTISA-N 0.000 description 1
- GVCQOCWTKDZTSS-UHFFFAOYSA-N n-benzyl-7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(CN(C2)C(=O)NCC=3C=CC=CC=3)CC2CN1CC(O)COC1=CC=C(C#N)C=C1 GVCQOCWTKDZTSS-UHFFFAOYSA-N 0.000 description 1
- WZUYKLHIMHAIOK-UHFFFAOYSA-N n-ethyl-7-[2-(4-nitrophenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCC1=CC=C([N+]([O-])=O)C=C1 WZUYKLHIMHAIOK-UHFFFAOYSA-N 0.000 description 1
- QQJAVWJQUYCMLU-UHFFFAOYSA-N n-ethyl-7-[2-[4-(methanesulfonamido)phenyl]ethyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CCC1=CC=C(NS(C)(=O)=O)C=C1 QQJAVWJQUYCMLU-UHFFFAOYSA-N 0.000 description 1
- NTLGLKJRXJSWGD-UHFFFAOYSA-N n-phenyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1C(C2)CNCC2CN1C(=O)NC1=CC=CC=C1 NTLGLKJRXJSWGD-UHFFFAOYSA-N 0.000 description 1
- SVKQLFZZQCGXKG-UHFFFAOYSA-N n-propan-2-yl-3,7-diazabicyclo[3.3.1]nonane-3-carboxamide Chemical compound C1NCC2CN(C(=O)NC(C)C)CC1C2 SVKQLFZZQCGXKG-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- UXOFXTUCXRNLFA-UHFFFAOYSA-N phenyl-(7-propan-2-yl-3,7-diazabicyclo[3.3.1]nonan-3-yl)methanone Chemical compound C1N(C(C)C)CC(C2)CC1CN2C(=O)C1=CC=CC=C1 UXOFXTUCXRNLFA-UHFFFAOYSA-N 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- BIFDXOOJPDHKJH-UHFFFAOYSA-N piperidine-1-carbonyl chloride Chemical compound ClC(=O)N1CCCCC1 BIFDXOOJPDHKJH-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- GKTBTTJFVIKLPR-UHFFFAOYSA-N propan-2-yl n-[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carbonyl]carbamate Chemical compound C1N(C(=O)NC(=O)OC(C)C)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 GKTBTTJFVIKLPR-UHFFFAOYSA-N 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000012418 sodium perborate tetrahydrate Substances 0.000 description 1
- IBDSNZLUHYKHQP-UHFFFAOYSA-N sodium;3-oxidodioxaborirane;tetrahydrate Chemical compound O.O.O.O.[Na+].[O-]B1OO1 IBDSNZLUHYKHQP-UHFFFAOYSA-N 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- CTIRHWCPXYGDGF-HDICACEKSA-N tedisamil Chemical compound [H][C@]12CN(CC3CC3)C[C@]([H])(CN(CC3CC3)C1)C21CCCC1 CTIRHWCPXYGDGF-HDICACEKSA-N 0.000 description 1
- 229960002926 tedisamil Drugs 0.000 description 1
- FFDOXSIZJSGXOQ-UHFFFAOYSA-N tert-butyl 7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC(C2)CC1CN2CC(O)COC1=CC=C(C#N)C=C1 FFDOXSIZJSGXOQ-UHFFFAOYSA-N 0.000 description 1
- MKIDXJCTFKMWLU-UHFFFAOYSA-N tert-butyl 7-[4-(4-cyanophenyl)-4-(3,4-dimethoxyphenoxy)butyl]-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate Chemical compound C1=C(OC)C(OC)=CC=C1OC(C=1C=CC(=CC=1)C#N)CCCN1CC(CN(C2)C(=O)OC(C)(C)C)CC2C1 MKIDXJCTFKMWLU-UHFFFAOYSA-N 0.000 description 1
- VQDJQZYAGLJHBU-XVAXZDLZSA-N tert-butyl n-[(2r)-1-(4-cyanophenoxy)-3-[3-(ethylcarbamoyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]propan-2-yl]carbamate Chemical compound C([C@@H](CN1CC2CC(C1)CN(C2)C(=O)NCC)NC(=O)OC(C)(C)C)OC1=CC=C(C#N)C=C1 VQDJQZYAGLJHBU-XVAXZDLZSA-N 0.000 description 1
- HUSKDFBLDUETRA-UHFFFAOYSA-N tert-butyl n-[1-(3-carbamoyl-3,7-diazabicyclo[3.3.1]nonan-7-yl)-3-(4-cyanophenoxy)propan-2-yl]carbamate Chemical compound C1C(CN(C2)C(N)=O)CC2CN1CC(NC(=O)OC(C)(C)C)COC1=CC=C(C#N)C=C1 HUSKDFBLDUETRA-UHFFFAOYSA-N 0.000 description 1
- VQDJQZYAGLJHBU-UHFFFAOYSA-N tert-butyl n-[1-(4-cyanophenoxy)-3-[3-(ethylcarbamoyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]propan-2-yl]carbamate Chemical compound C1N(C(=O)NCC)CC(C2)CC1CN2CC(NC(=O)OC(C)(C)C)COC1=CC=C(C#N)C=C1 VQDJQZYAGLJHBU-UHFFFAOYSA-N 0.000 description 1
- PBLFDLOXAJNCGB-UHFFFAOYSA-N tert-butyl n-[1-(4-cyanophenoxy)-3-[3-(oxan-2-ylcarbamoyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]propan-2-yl]carbamate Chemical compound C1C(CN(C2)C(=O)NC3OCCCC3)CC2CN1CC(NC(=O)OC(C)(C)C)COC1=CC=C(C#N)C=C1 PBLFDLOXAJNCGB-UHFFFAOYSA-N 0.000 description 1
- RSALOVQEGAJNJH-UHFFFAOYSA-N tert-butyl n-[1-(4-cyanophenoxy)-3-[3-(propanoylcarbamoyl)-3,7-diazabicyclo[3.3.1]nonan-7-yl]propan-2-yl]carbamate Chemical compound C1N(C(=O)NC(=O)CC)CC(C2)CC1CN2CC(NC(=O)OC(C)(C)C)COC1=CC=C(C#N)C=C1 RSALOVQEGAJNJH-UHFFFAOYSA-N 0.000 description 1
- WPXMQHNCZJXSCW-UHFFFAOYSA-N tert-butyl n-[3-(4-cyanophenoxy)-2-hydroxypropyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC(O)COC1=CC=C(C#N)C=C1 WPXMQHNCZJXSCW-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
On décrit des composés de formule (I) dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿, R?7¿, R?41¿, R?42¿, R?43¿, R?44¿, R?45¿, R?46¿, A et B sont tels que définis dans le descriptif. Ces composés sont utiles pour la prophylaxie et le traitement des arythmies, plus particulièrement des arythmies atriale et ventriculaire.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902268A SE9902268D0 (sv) | 1999-06-16 | 1999-06-16 | Pharmaceutically active compounds |
| SE9902268-3 | 1999-06-16 | ||
| PCT/SE2000/001254 WO2000077000A1 (fr) | 1999-06-16 | 2000-06-15 | Nouveaux composes de bispidine utiles dans le traitement des arythmies cardiaques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2375841A1 true CA2375841A1 (fr) | 2000-12-21 |
Family
ID=20416100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002375841A Abandoned CA2375841A1 (fr) | 1999-06-16 | 2000-06-15 | Nouveaux composes de bispidine utiles dans le traitement des arythmies cardiaques |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1192157A1 (fr) |
| JP (1) | JP2003502329A (fr) |
| KR (1) | KR20020010713A (fr) |
| CN (1) | CN1144805C (fr) |
| AR (1) | AR024577A1 (fr) |
| AU (1) | AU761576B2 (fr) |
| BR (1) | BR0011660A (fr) |
| CA (1) | CA2375841A1 (fr) |
| CZ (1) | CZ20014495A3 (fr) |
| EE (1) | EE200100675A (fr) |
| HK (1) | HK1045520A1 (fr) |
| HU (1) | HUP0203959A3 (fr) |
| IL (1) | IL146754A0 (fr) |
| IS (1) | IS6201A (fr) |
| MX (1) | MXPA01012919A (fr) |
| NO (1) | NO20016117L (fr) |
| NZ (1) | NZ516013A (fr) |
| PL (1) | PL354032A1 (fr) |
| RU (1) | RU2250903C2 (fr) |
| SE (1) | SE9902268D0 (fr) |
| SK (1) | SK18272001A3 (fr) |
| TR (1) | TR200103663T2 (fr) |
| WO (1) | WO2000077000A1 (fr) |
| ZA (1) | ZA200109796B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR030302A1 (es) * | 2000-07-07 | 2003-08-20 | Astrazeneca Ab | Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios |
| SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New crystalline forms |
| TWI499418B (zh) * | 2009-05-21 | 2015-09-11 | Nerviano Medical Sciences Srl | 異喹啉-1(2h)-酮衍生物 |
| US9169198B2 (en) * | 2011-07-08 | 2015-10-27 | Bayer Intellectual Property Gmbh | Method for the production of 2-amino-5-cyano-N,3-dimethylbenzamide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1107541A1 (ru) * | 1982-12-03 | 1995-10-20 | Институт Тонкой Органической Химии Им.А.Л.Мнджояна | 10-нитро-1,6,8-триазатрицикло [6,3,1,1] тридекан-2,5-дион |
| PT88381B (pt) * | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos |
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| DK588489D0 (da) * | 1989-11-22 | 1989-11-22 | Ferrosan As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| TW263504B (fr) * | 1991-10-03 | 1995-11-21 | Pfizer | |
| US5468858A (en) * | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
| SE9704709D0 (sv) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
-
1999
- 1999-06-16 SE SE9902268A patent/SE9902268D0/xx unknown
-
2000
- 2000-06-15 CZ CZ20014495A patent/CZ20014495A3/cs unknown
- 2000-06-15 KR KR1020017016168A patent/KR20020010713A/ko not_active Withdrawn
- 2000-06-15 AU AU60324/00A patent/AU761576B2/en not_active Ceased
- 2000-06-15 WO PCT/SE2000/001254 patent/WO2000077000A1/fr not_active Ceased
- 2000-06-15 TR TR2001/03663T patent/TR200103663T2/xx unknown
- 2000-06-15 JP JP2001503858A patent/JP2003502329A/ja active Pending
- 2000-06-15 MX MXPA01012919A patent/MXPA01012919A/es unknown
- 2000-06-15 CA CA002375841A patent/CA2375841A1/fr not_active Abandoned
- 2000-06-15 CN CNB008116962A patent/CN1144805C/zh not_active Expired - Fee Related
- 2000-06-15 RU RU2001132563/04A patent/RU2250903C2/ru not_active IP Right Cessation
- 2000-06-15 SK SK1827-2001A patent/SK18272001A3/sk unknown
- 2000-06-15 EP EP00946589A patent/EP1192157A1/fr not_active Withdrawn
- 2000-06-15 EE EEP200100675A patent/EE200100675A/xx unknown
- 2000-06-15 HK HK02107165.2A patent/HK1045520A1/zh unknown
- 2000-06-15 NZ NZ516013A patent/NZ516013A/xx unknown
- 2000-06-15 PL PL00354032A patent/PL354032A1/xx not_active Application Discontinuation
- 2000-06-15 IL IL14675400A patent/IL146754A0/xx unknown
- 2000-06-15 HU HU0203959A patent/HUP0203959A3/hu unknown
- 2000-06-15 BR BR0011660-2A patent/BR0011660A/pt not_active IP Right Cessation
- 2000-06-16 AR ARP000103015A patent/AR024577A1/es not_active Application Discontinuation
-
2001
- 2001-11-28 ZA ZA200109796A patent/ZA200109796B/en unknown
- 2001-12-14 NO NO20016117A patent/NO20016117L/no not_active Application Discontinuation
- 2001-12-14 IS IS6201A patent/IS6201A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6032400A (en) | 2001-01-02 |
| IL146754A0 (en) | 2002-07-25 |
| CZ20014495A3 (cs) | 2002-05-15 |
| CN1144805C (zh) | 2004-04-07 |
| KR20020010713A (ko) | 2002-02-04 |
| NO20016117D0 (no) | 2001-12-14 |
| AR024577A1 (es) | 2002-10-16 |
| HK1045520A1 (zh) | 2002-11-29 |
| WO2000077000A1 (fr) | 2000-12-21 |
| IS6201A (is) | 2001-12-14 |
| AU761576B2 (en) | 2003-06-05 |
| CN1370167A (zh) | 2002-09-18 |
| ZA200109796B (en) | 2003-02-28 |
| HUP0203959A3 (en) | 2003-04-28 |
| EP1192157A1 (fr) | 2002-04-03 |
| SE9902268D0 (sv) | 1999-06-16 |
| BR0011660A (pt) | 2002-03-26 |
| JP2003502329A (ja) | 2003-01-21 |
| RU2250903C2 (ru) | 2005-04-27 |
| EE200100675A (et) | 2003-02-17 |
| WO2000077000A9 (fr) | 2003-06-19 |
| TR200103663T2 (tr) | 2002-05-21 |
| NO20016117L (no) | 2002-02-15 |
| SK18272001A3 (sk) | 2002-12-03 |
| PL354032A1 (en) | 2003-12-15 |
| NZ516013A (en) | 2003-06-30 |
| HUP0203959A2 (hu) | 2003-03-28 |
| MXPA01012919A (es) | 2002-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1047695B1 (fr) | Nouveaux composes de bispidine antiarythmiques | |
| EP2265611A1 (fr) | Dérivés tricycliques en tant qu inhibiteurs de poly(adp-ribose)polymérase (parp) | |
| CA2375841A1 (fr) | Nouveaux composes de bispidine utiles dans le traitement des arythmies cardiaques | |
| US7012074B2 (en) | 3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias | |
| US20040229900A1 (en) | Bispidine compounds useful in the treatment of cardiac arrythmias | |
| EP1192154B1 (fr) | Composes de bispidine utiles dans le traitement des arythmies cardiaques | |
| EP1301510A1 (fr) | Nouveaux composes de bispidine et leur utilisation dans le traitement des arythmies cardiaques | |
| EP1192156B1 (fr) | Composes de bispidine pouvant etre utilises pour le traitement de l'arythmie cardiaque | |
| US20030212095A1 (en) | New bispidine compounds and their use in the treatment of cardiac arrhythmias | |
| US20050004113A1 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |